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Ferritin plays a central role in iron metabolism by acting both as iron storage and 
detoxifying protein. We have generated a ferritin H allele with loxP sites and studied the 
conditional ferritin H deletion in adult mice. Ten days after Mx-Cre induced deletion, 
ferritin H mRNA was below 5% in the liver, spleen and bone marrow of deleted mice 
compared to control littermates. Mice lost their cellular iron stores indicating the 
requirement of ferritin H in iron deposition. Serum iron and transferrin saturation were 
slightly increased and correlated with a 2-fold increased liver hepcidin 1 mRNA and a 
reduced duodenal DcytB mRNA level. Under normal iron regimen, deleted mice 
survived for 2 years without visible disadvantage. Mice fed on a high iron diet prior to 
ferritin H deletion suffered from severe liver damage. Similarly, ferritin H deleted 
mouse embryonic fibroblasts showed rapid cell death after exposure to iron salt in the 
medium. This was reversed by wildtype ferritin H but not by a ferritin H mutant lacking 
ferroxidase activity. Cell death was preceded by an increase in cytoplasmic free iron, 
reactive oxygen species, and mitochondrial depolarization. Conclusion: Our results 
provide evidence that the iron storage function of ferritin plays a major role in 
preventing iron-mediated cell and tissue damage. 
 
  
4
Protein shells of 24 ferritin H and L subunits can accumulate up to 4500 iron atoms as Fe3+ in 
all tissues, but most prominently in hepatocytes and reticuloendothelial cells of liver and 
spleen.1 The ferritin H subunit has a ferroxidase activity needed for iron deposition.2,3 
Translation of both subunits is regulated by iron regulatory proteins 1 and 2 (IRP1 and IRP2) 
in response to iron availability.4 Thus, the amount of ferritin adapts to body iron levels. Iron 
stored in ferritin can be mobilized prior to ferritin degradation.5 Ferritin’s iron scavenging 
function is also thought to prevent iron-mediated catalysis of reactive oxygen species (ROS), 
which provoke tissue damage6 and may cause cancer7 and neurodegeneration.8 
 
Previous studies in mice found that a straight knock-out of the ferritin H (Fth) gene provokes 
embryonic lethality.9 Until now, this has hampered studying potential other functions of 
ferritin in vivo. Ferritin might contribute iron for cell proliferation of lymphoid cells10 and 
complement extracellular iron uptake from transferrin by transferrin receptor.11 Ferritin was 
also postulated to scavenge excess iron from nutrition in duodenal cells, known as the 
“mucosal block” hypothesis.12,13 Under this hypothesis, when body iron stores are high and 
ferritin synthesis in crypt cells increased, mature villus cells might retain iron and prevent its 
basolateral release to serum. This view is not formally excluded, but challenged by the 
discovery of the peptide hormone hepcidin 1.14,15 The relative importance of ferritin versus 
hepcidin 1 remains therefore to be investigated. Hepcidin 1 expression is regulated by body 
iron levels and essential for the control of iron absorption.14-16 Hepcidin 1 may either repress 
mRNA of iron transporters through signaling17,18 and/or interfere directly with basolateral iron 
export by binding to ferroportin.19 Ferritin also retains iron in reticuloendothelial cells during 
anemia of acute or chronic inflammation, but it remains unknown whether ferritin synthesis is 
the cause or result of iron retention. Again, hepcidin 1, induced by inflammatory cytokines, 
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might favor iron retention by controlling iron efflux via ferroportin.19,20 Finally, it was 
debated whether ferritin is important in providing iron for heme biosynthesis.21,22 
 
Here we have generated mice carrying loxP sites 5’ of the Fth gene promoter and 3’ of exon 1 
in order to delete ferritin H expression in adult mice by Cre recombinase. We have 
conditionally deleted the Fth gene in adult male mice using Cre under the control of the poly-
IC inducible Mx gene promoter.23 This deletes ferritin H almost completely in liver, bone 
marrow, spleen and thymus, but less prominently in other tissues. We report here the effects 
on iron storage, iron toxicity, hematological parameters and cell viability. We have explored 
effects of iron overload before or after ferritin H deletion and found rapid cell death in the 
liver and in mouse embryonic fibroblasts derived from our mice. In cultured cells, the cause 
of death could be attributed to ROS, mitochondrial depolarization and permeability transition. 
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Experimental procedures 
 
All experimental procedures are accessible as “Supplementary Materials and Methods”.  
 
Results 
 
Conditional ferritin H deletion is lethal in embryos 
To study the function of ferritin H in adult mice, we have generated, by embryonic stem cell 
recombination, mice with a modified ferritin H allele referred to as FthloxNeo. In this allele, the 
ferritin H promoter and exon 1 are bordered by loxP sites that also flank a neomycin selection 
cassette between FRT sites (Supplementary fig. 1). To verify our ferritin H targeting strategy, 
we crossed FthloxNeo mice with hemizygous nestin-Cre1 mice.24 The nestin promoter shows a 
complex expression pattern with activity in the brain as well as in the germ line.24 Therefore, 
complete deletion of ferritin H was expected to occur in FthloxNeo/+;Nes-Cre1 animals. Of 38 
F2 mice, 17 (44.7%) were Fth+/+ and 21 (55.3%) were Fth+/– confirming nestin-Cre induced 
deletion. No Fth–/– mice were born indicating an essential function of ferritin H in 
embryogenesis. These results are best explained by a germ-line deletion of ferritin H in the 
FthloxNeo/+;Nes-Cre1 F1 generation24 with embryonic lethality when the Fth gene is absent 
from germ cells.9 They are in agreement with previously published studies on embryonic 
lethality of ferritin deletion in mice. 
 
Ferritin H deletion in adult animals induces loss of iron storage 
For all subsequent experiments we used Fthlox/lox mice derived by breeding FthloxNeo/loxNeo mice 
with mice transgenic for Flp recombinase. Fthlox/lox mice were crossed with transgenic Mx-Cre 
mice to obtain experimental Fthlox/lox;Mx-Cre and control Fthlox/lox littermates. Initially, mice 
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were of mixed genetic background (C57 BL/6 x 129/Sv), but with advancement of the 
analysis, mice were 10 times backcrossed with C57BL/6J mice. Upon induction by poly I/C, 
the ferritin H gene deletion was analyzed in adult male mice (Fig. 1A). Liver, spleen and bone 
marrow showed an almost complete loss in the ferritin H gene and mRNA. In parallel, ferritin 
H protein was rapidly lost (Figs 1B and 1C). However, staining for ferritin L was enhanced 
(Fig. 1B), possibly due to increased ferritin L translation after IRP1 and IRP2 inactivation by 
iron liberated upon ferritin H degradation.4 Concomitant with the loss of ferritin H mRNA, 
liver and spleen showed a marked decrease in tissue iron (Fig. 1A). In duodenum and heart, 
ferritin H mRNA was significantly reduced, but not enough to affect iron storage (Fig. 1A), 
whereas in kidney and lung, ferritin H was poorly deleted as expected.23 Histochemical 
analysis showed also a complete loss of iron deposits in spleen reticuloendothelial cells of 
Fth∆/∆ mice (Fig. 1D). This was not due to the loss of reticuloendothelial cells (Fig. 1E). Liver 
iron deposits were too low to be detected by this method, or by DAB-enhanced iron staining.  
 
Ferritin is not required for hemoglobin synthesis  
Most iron is recycled from hemoglobin of senescent erythrocytes, by the reticuloendothelial 
cells, and subsequently reincorporated into fresh hemoglobin in erythroid precursor cells. 
Therefore, it was of interest to observe whether Mx-Cre induced ferritin H deletion (Fig. 1A) 
would modify hemoglobin and hematocrit levels. Fth∆/∆ mice showed no significant difference 
compared to Fthlox/lox mice (Supplementary table 1), and they survived for 2 years without 
noticeable disadvantage, while the extent of deleted cells remained unchanged. It suggests 
that ferritin H is not essential for iron recycling by macrophages and erythroid heme-
biosynthesis. We further tested whether mice without ferritin H in liver and spleen showed 
changes in serum iron levels and transferrin saturation at 3, 10 and 30 days after ferritin H 
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deletion (Fig. 2B). A mild, but significant increase was observed for both parameters in 
experimental versus control mice.  
 
Effects of Mx-Cre mediated ferritin H deletion on gene expression  
Real-time PCR in Fth∆/∆ versus Fthlox/lox mice at various time-points revealed a significant 
increase of liver hepcidin 1 mRNA (Fig. 2A). This increase correlated with increased serum 
iron (Fig. 2B) and transferrin saturation (Fig. 2C). Among mRNAs coding for proteins of 
duodenal iron transport, only Dcytb mRNA was significantly repressed, whereas mRNA of 
DMT1, ferroportin, and hephaestin showed no significant change (Fig. 2A and data not 
shown). Liver mRNAs of ferritin L, transferrin and Hfe were unchanged. Transferrin receptor 
1 mRNA was slightly reduced in most tissues, compatible with mRNA destabilization due to 
IRP inactivation.25 The mRNAs for transferrin receptor 2, superoxide dismutase 2 and 
glutathione peroxidase 1 remained unchanged in liver and intestine. 
 
Severe liver damage by ferritin H deletion in animals with high iron diet  
As Fth∆/∆ mice on C57BL/6 background showed only mild changes, we investigated how well 
they would endure increased iron levels after feeding with iron-rich diet. As expected, they 
accumulated 8 times more iron in the liver and showed a 3.2-fold increase in hepcidin 1 
mRNA (Figs 3B and C). Concomitantly, ferritin H was strongly induced (Fig. 3A, lane 2). 
Upon Fth gene deletion, ferritin H disappeared rapidly (Fig. 3A, lane 3) and tissue iron levels 
dropped to 39% within 5 days (Fig. 3B). Perl’s staining of non-deleted liver sections showed 
diffuse iron staining in hepatocytes near blood vessels. Five days after deletion, the staining 
was weaker with a more granular appearance but no change in distribution (Fig 3G). Iron 
release from iron-loaded tissue did not sustain hepcidin 1 expression (Fig. 3C). Most 
prominently, these mice showed severe signs of illness and had to be sacrificed 5 days after 
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poly-IC injection. Their livers were swollen with a 42% increased wet weight. Liver tissue 
sections showed signs of irreversible cell damage with enlarged nuclei, macrosteatosis, 
hemorrhage and infiltration by polymorphonuclear cells (Fig 3E). Liver damage was 
confirmed by the terminal transferase dUTP nick end labeling (TUNEL) assay, which showed 
significantly more DNA strand breaks in iron-loaded Fth∆/∆ mice than iron-loaded Fthlox/lox 
mice or mice on normal iron diet (Fig. 3F). Quantification of TUNEL staining in 7 fields of 4 
independent animals (≅1500 cells) showed 9.4±5.3% stained cells for iron-loaded Fth∆/∆ mice 
versus 1.8±0.4% for iron-loaded Fthlox/lox mice (p value<0.025). For normally fed Fth∆/∆ and 
Fthlox/lox mice the values were 1.0±0.7% and 0.9±0.3%, respectively. Alanine transaminase 
(ALT) and aspartate transaminase (AST) activity in serum was also strongly increased (Fig. 
3D). In addition, mRNA of heme oxygenase 1, a gene responding to oxidant signals, was 
induced 13-fold in iron-loaded Fth∆/∆ versus Fthlox/lox mice. When non-loaded Fth∆/∆ mice were 
injected with iron-dextran 2 months after ferritin H deletion, they showed the same acute liver 
damage as those pre-loaded with iron (not shown). 
 
We questioned whether poly-IC was responsible for liver damage, possibly by triggering an 
inflammatory response. Therefore, we crossed Fthlox/lox mice with SA-Cre-ERT2 mice 
expressing tamoxifen-inducible Cre under control of the hepatocyte-specific serum albumin 
promoter, which leaves the ferritin H gene intact in liver macrophages.26 Tamoxifen 
activation of Cre-ERT2 in 10-week old iron-loaded mice reduced liver ferritin H mRNA to 6-
15% at day 10, reflecting the hepatocyte-specific deletion. Perl’s staining prior to the deletion 
was similar to the one in Fthlox/lox;Mx-Cre mice (Fig 3H). At day 10 after deletion, however, 
the staining in Fth∆/∆;SA-Cre-ERT2 mice looked very different from the one in Fth∆/∆;Mx-Cre 
mice. Noticably, hepatocytes did not show iron staining, but some iron remained highly 
concentrated in a few cells, which we identified as macrophages and in rare instances as 
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hepatocytes. Importantly, unlike Fth∆/∆;Mx-Cre mice, the Fth∆/∆;SA-Cre-ERT2 mice showed 
no signs of liver damage (Supplementary fig. 2). In order to create conditions similar to the 
Cre activation in Mx-Cre mice, poly-IC was injected together with tamoxifen. These mice 
showed again no signs of liver damage (not shown). We conclude that liver damage in 
Fth∆/∆;Mx-Cre mice is not due to poly-IC, but rather iron toxicity. 
 
Iron induced cell death of Fth∆/∆ mouse embryonic fibroblasts  
To study the mechanism of cellular iron toxicity, we derived Fth∆/∆ and Fth+/∆ mouse 
embryonic fibroblasts, which showed identical cell proliferation rates and viability in absence 
of iron salts. However, upon exposure to ferric ammonium citrate, Fth∆/∆ cells were 30-fold 
more sensitive to iron (LD50=1.3 μg/ml) than FthloxNeo/loxNeo cells (LD50=36 μg/ml) and 120-
fold more than Fth+/∆ cells (LD50=151 μg/ml) (Fig. 4A). Fth∆/∆ cell death could be rescued by 
wildtype ferritin H using an inducible vector (Fig. 4B). No rescue was observed upon 
expression of mutant ferritin H lacking ferroxidase activity (Fig. 4B). In all cell populations 
tested LD50 values correlated well with ferritin mRNA levels (Fig. 4C). Together, these data 
indicate an essential role of ferritin in the protection against iron toxicity.  
 
To analyze directly whether increased cytoplasmic iron correlates with cell death, we 
measured IRP activity by an mRNA translation assay with unstable d2EGFP reporter linked 
to the 5’-iron responsive element of mouse ferritin L. In this assay, low cytoplasmic iron 
increases IRP activity, which represses d2EGFP translation. When free iron increases, IRP is 
inactivated and translation repression relieved. Thus, measuring d2EGFP steady state levels 
by FACS (Supplementary fig. 5) reflects cytoplasmic free iron levels. d2EGFP expression 
was increased 80% or more with iron concentrations at the LD50 or above. To reach an 
increased free iron pool, Fth∆/∆ cells needed much lower extracellular iron concentrations than 
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FthloxNeo/loxNeo cells (Fig. 5A). The increase in free iron correlated with an enhanced 
accumulation of ROS as measured by dichlorofluorescein (DCF) already 3h after the addition 
of ferric ammonium citrate to cells (Fig. 5B). After 16 h cells showed signs of mitochondrial 
depolarization and membrane permeability at or above the LD50 iron level (Fig. 5C and 
Supplementary fig. 6). Several inhibitors of oxidant activity were able to prevent 
mitochondrial depolarization and permeability transition (Fig. 5D). Notably mitoquinone 
diminished iron toxicity strongly. Cells also underwent mitochondrial permeability transition, 
which was clearly visible in FthloxNeo/loxNeo cells exposed to high iron concentrations needed 
for mitochondrial depolarization (Supplementary fig. 7). This effect was, however, not visible 
in Fth∆/∆ at lower iron concentrations, which nonetheless induced depolarization. It indicates 
that mitochondrial permeability transition was not a prerequisite for mitochondrial 
depolarization.  
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Discussion 
 
Our data provide clear evidence for the requirement of ferritin H in iron storage and 
detoxification. We conclude that iron storage in vivo cannot be maintained by ferritin L alone. 
The importance of ferritin H and its ferroxidase activity for ferritin assembly and iron 
deposition was previously described in vitro and for cell lines with diminished or increased 
ferritin H levels.27,28 Our results extend these studies to tissues under physiological conditions. 
As iron stores and ferritin H are rapidly reduced in deleted tissues, we conclude that ferritin is 
continuously degraded. This agrees with reports of ferritin half-lives of 3 days in rat liver29 
and <24 h in tissue culture cells.30 Thus, iron stores are dynamic making the metal 
continuously available for the biosynthesis of iron-containing proteins. Upon Fth gene knock-
out, iron cannot be redeposited into ferritin and leaves the tissue as observed for spleen and 
liver. It explains the increased serum iron and transferrin saturation. However, about 20 to 
40% of the non-heme liver iron remained with a granular appearance, and further work is 
required to resolve the identity of these non-degradable iron deposits. Attempts to trace the 
redistribution of iron showed no significant increase in other tissues (Fig. 1A), possibly 
because C57BL/6 mice accumulate modest hepatic iron stores.31 Studies using 59Fe should 
detail this further.  
 
Hepcidin 1 is central to the regulation of intestinal iron absorption and iron recycling from 
reticulocytes.14-16,19,20 Our results showing a correlation between hepcidin 1 mRNA induction 
and the increase in serum iron and transferrin saturation seem to reflect an iron- or holo-
transferrin-dependent signaling to the hepcidin 1 gene.14,32 More surprising is the diminished 
hepcidin 1 mRNA expression in animals fed with high iron and then deleted of ferritin H (Fig. 
3C). However, proper cell responsiveness and signaling to the hepcidin 1 gene might be 
  
13
altered by severe liver damage. We and others have observed that isolated primary 
hepatocytes in cell culture show diminished hepcidin 1 mRNA expression and are 
unresponsive to ferric iron in the medium (L. Vanoaica, unpublished observation)14,33 unless 
treated within few hours with iron-loaded holo-transferrin.32  
 
The acute liver damage observed within just a few days of the ferritin H deletion in iron-
loaded Mx-Cre mice can neither be attributed to iron loading alone, nor to activation of the 
interferon-α pathway by poly-IC, as control mice showed no signs of damage. Our results in 
the hepatocyte-specific SA-Cre-ERT2-mediated ferritin H deletion with tamoxifen, or with 
tamoxifen plus poly-IC, also exclude that poly-IC alone provokes liver damage. Cell death 
appears, therefore, directly related to iron liberated upon ferritin H deletion and degradation. 
Whether liberated iron is sufficient to provoke liver damage or involves signals due to ferritin 
deletion in other tissues remains to be investigated. The fact that ferritin H deleted mice fed 
with normal diet for 2 months and then injected with iron dextran show acute liver failure, 
argues in favor of a direct effect of iron toxicity on liver cells. Interestingly, the hepatocyte-
specific SA-Cre-ERT2-mediated ferritin H deletion does not provoke damage (Supplementary 
fig. 2). This suggests that hepatocytes are protected because adjacent macrophages absorb 
large amounts of liberated iron (Fig. 3), which is not the case in Mx-Cre mice.  
 
We have gained mechanistic insight into the cause of iron toxicity in embryonic fibroblasts 
and show again that ferritin H protects against iron toxicity (Fig. 4). The protection depends 
directly on the capacity of ferritin to store iron, since the ferritin H deletion can be rescued by 
wildtype ferritin H, but not a mutant which lost its ferroxidase activity and iron storage 
capacity.3, 27 As a first consequence of the ferritin H deletion, the intracellular free iron pool is 
increased as assessed by the relief of translation regulation of an iron responsive element 
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containing GFP reporter construct (Fig.5). This completes previous conclusions drawn in 
K562 cells where ferritin H overexpression reduced the free iron pool.34 Probably as a direct 
consequence, ROS increased rapidly within 3 h in Fth∆/∆ cells, even at low extracellular iron 
concentrations. While the causative connection between free iron and ROS is well 
documented, we confirm that ferritin H expression is absolutely essential to prevent ROS 
formation. Others have shown that siRNA-mediated knock-down of ferritin H in K562 cells 
increased free iron and ROS production,35 and rendered cells more sensitive to H2O2.28 
Moreover, ferritin H induction by NF-κB can counteract TNFα induced apoptosis by 
scavenging iron and preventing ROS formation.6 We extend these previous observations to 
the death mechanism with evidence that mitochondrial depolarization and permeability 
transition precede cell death. Mitochondrial depolarization appears to be direct consequence 
of iron-mediated ROS formation as they show similar iron dose response curves with a 
marked difference between Fth∆/∆ and FthloxNeo/loxNeo cells. The causative relationship is further 
underlined by the time-delay between ROS formation and mitochondrial depolarization, as 
well as the fact that inhibitors with anti-oxidant functions inhibit mitochondrial depolarization 
significantly. Iron was previously implicated in cold-induced apoptosis and shown to trigger 
mitochondrial permeability transition in hepatocytes.36 ROS and mitochondrial permeability 
transition plays also a role in ischemia-reperfusion injury and iron poisoning.37 Whether the 
liver damage observed in our Mx-Cre deleted mice is a direct consequence of mitochondrial 
depolarization remains to be studied. Our mice should become particularly useful to evaluate 
the role of iron-catalyzed ROS in specific tissues, and to establish the function of ferritin not 
only in acute iron toxicity, but also in long-term protection against DNA mutagenesis and 
aging. 
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Figure legends 
 
Figure 1. Conditional ferritin H deletion by Mx-Cre reduces iron storage in liver and 
spleen. Ten week old Fthlox/lox;Mx-Cre and control Fthlox/lox mice were injected with poly-IC 
to activate Cre expression. A. At day 10, the ferritin H deletion was assessed in different 
tissues by real-time PCR on genomic DNA (green) and ferritin H cDNA (blue). Tissue iron 
content (red) was measured by the bathophenanthroline method. Values in Fth∆/∆ mice (n=4) 
are expressed in % of values in Fthlox/lox mice (n=4) set as 100% ± standard deviation (SD). B. 
Immunofluorescence staining of ferritin H and L in frozen liver sections (day 10). Scale bar, 
200 μm. C. Immunoblot analysis of liver ferritin H in one Fthlox/lox mouse and two Fth∆/∆ mice 
at days 3 and 10. D. Frozen spleen sections stained by Perl’s Prussian blue at day 30. Scale 
bar, 200 μm. E. Frozen spleen sections stained for macrophages with anti-CD11b and anti-
F4/80 antibodies, as well as 4',6-diamidino-2-phenylindole (DAPI). Scale bar, 100 μm. 
 
Figure 2. Ferritin H deletion causes increase of serum iron, transferrin saturation and 
liver hepcidin 1 mRNA, and repression of duodenal Dcytb mRNA. A. mRNA expression 
was tested by real-time PCR at days 3, 10 and 30 after ferritin H deletion using primers 
indicated in Supplementary table 2. Average expression (arbitrary units) for Fthlox/lox mice 
(n=6;3;3) and Fth∆/∆ mice (n=6;3;3) was normalized to the geometric average of 2 control 
genes (GAPDH and HPRT in liver; GAPDH and β-actin in intestine) ± SD. *** p<0.0005; * 
p<0.05. B. Serum iron levels and transferrin saturation. * p<0.05. C.  Transferrin saturation 
correlated with hepcidin 1 mRNA expression in Fthlox/lox (○) and Fth∆/∆ (●) mice (R=0.701 
and p<0.0002). 
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Figure 3. Severe physiological consequences of ferritin H deletion in iron-loaded mice. 
Mice were fed 14 days with 2.5% carbonyl iron diet prior to Mx-Cre induction and analyzed 
at day 5. A. Immunoblot of liver proteins probed with anti-ferritin H and control anti γ-tubulin 
antibodies. B. Liver iron in Fthlox/lox mice without (−Fe) (n=4) or with (+Fe) high iron diet 
(n=4) was compared to iron-loaded Fth∆/∆ mice (n=4). C. Hepcidin 1 mRNA (arbitrary units) 
of the same mice as in B. was normalized to TATA box binding protein mRNA. D. 
Cytoplasmic liver enzyme activity of alanine transaminase (ALT) and aspartate transaminase 
(AST) in serum. *** p<0.0005; ** p<0.005; * p<0.05. E. Morphological changes in liver 
tissue sections stained with hematoxylin-eosin of iron-loaded Fthlox/lox (a) and Fth∆/∆ mice (b 
to d) analyzed at day 5. Scale bar 100 μm. The sections of Fth∆/∆ mice show extensive 
macrosteatosis (b), hemorrhage (c) and polymorphonuclear cell infiltration (d) with 
neutrophils (insert; scale bar 5 μm). Enlarged version in Supplementary fig. 3. F. TUNEL 
assay on frozen liver sections from normal and iron-loaded Fthlox/lox and Fth∆/∆ mice. Iron-
loaded Fth∆/∆ mice (d) show significantly more apoptotic or necrotic nuclei with DNA strand 
breaks. Scale bar 100 μm. G. Perl’s Prussian blue staining of liver in iron-loaded Fthlox/lox and 
Fth∆/∆ mice at day 5 after Mx-Cre activation by poly-IC. Scale bar 200 μm. H. Perl’s Prussian 
blue staining of liver in iron-loaded Fthlox/lox and Fth∆/∆ mice at day 10 after SA-Cre-ERT2 
activation with tamoxifen. Scale bar 200 μm. Enlarged version of panel G and H in 
Supplementary fig. 4. 
 
Figure 4. Survival of mouse embryonic fibroblasts in iron-rich medium depends on the 
presence of functional ferritin H. Mouse embryonic fibroblasts were derived from 
FthloxNeo/loxNeo and Fth+/loxNeo mice, transfected with CMV-Cre-ERT and exposed to tamoxifen 
to derive Fth∆/∆ and Fth+/∆ cells. A. Fth∆/∆ (○), FthloxNeo/loxNeo (●) and Fth+/∆ (◊) cells were 
incubated with increasing concentrations of ferric ammonium citrate and cell viability 
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measured after 4 days by the MTS assay. B. Fth∆/∆ cells were transfected with cDNA of 
wildtype ferritin H (■) or a ferritin H without ferroxidase activity due to 62E→K and 65H→G 
mutations (□). Iron toxicity was assessed as in A. C. Correlation between ferritin H mRNA 
expression and LD50 dose of ferric ammonium citrate. 
 
Figure 5. Iron toxicity in mouse embryonic fibroblasts involves increased cytoplasmic 
iron levels, ROS formation, and mitochondrial depolarization. A. FthloxNeo/loxNeo (●) and 
Fth∆/∆ (○) cells were infected with pSH-FTL-d2EGFP and unstable d2EGFP expression 
analyzed by the FACS at different iron concentrations (Supplementary fig. 5). Values report 
the fluorescence increase in d2EGFP-positive cells compared to conditions without iron 
addition (n=5). B. ROS formation was assessed by dichlorofluorescein (DCF) at 3, 6 and 16 h 
with different iron concentrations (n=3). C. Cells were stained at 6 or 16 h after ferric 
ammonium citrate addition with tetramethyl rhodamine methyl ester (TMRM) for 
mitochondrial depolarization (black bars) and 7-amino-actinomycin D (7aaD) for loss of 
membrane integrity (white bars) and analyzed by the FACS (Supplementary fig. 6). Values 
reflect the % of cells that shifted from normal to depolarized or to membrane permeable after 
subtracting background from untreated cells (n=5). D. Same assay as in C in the presence of 
inhibitors mitoquinone (MitoQ), Ebselen (Ebs), and trifluoroperazine (TFP) for 16 h (n=5). 
Inhibition was significant (p<0.05 by paired t-test) with all 3 inhibitors in Fth∆/∆ cells both for 
depolarization and cell death, whereas in FthloxNeo/loxNeo cells only depolarization was 
significantly inhibited by Ebselen and trifluoroperazine. 
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Supplementary Materials and Methods 
 
Generation and analysis of mutant mice. All work with mice was carried out in conformity 
with Swiss legal obligations of authorization for animal experimentation. To generate the 
FthloxNeo allele we amplified genomic DNA from BAC clone 409B1 of the RP-22 BAC library 
acquired from Children’s Hospital Oakland Research Institute. The 5' homologous arm (1.5 
kb), a deletion region (677 bp) containing 386 bp of the 5' flanking promoter and exon 1 of 
the ferritin H gene, and 3' homologous arm (2.5 kb) were cloned into vector tvFS1, a 
derivative of TNLOX1-3 into which a FRT/loxPneo cassette was inserted.1 The deletion 
region was flanked by loxP sites. The neomycin-resistance (Neo) cassette, flanked by two 
FRT sites, was used to select positive ES cell clones (Supplementary fig. 1A). Homologous 
recombinants in ES 129/Sv cells were identified first by PCR using primers in the Neo 
cassette and genomic upstream region as well as primers gFth1 and 2 (for primers see 
Supplementary table 2). Of 200 neomycin-resistant ES cell clones, 6 showed the correct 
arrangement for a recombination event. They were confirmed by genomic Southern blot 
analysis of an EcoRI digest with an intron 1 specific probe (Supplementary fig. 1B). Mutant 
ES cells were introduced into blastocysts of C57BL/6 mice to generate chimeras that 
transmitted the FthloxNeo allele through the germ-line. Mice carrying the FthloxNeo allele were 
genotyped by PCR (Supplementary fig. 1C). Primers used were gFth1 and 2 to detect the 
wildtype (419 bp) and floxed allele (337 bp). Subsequent to the exon 1 deletion by Cre 
recombinase, the Fth– allele was genotyped with primers gFth1 and 3, and gave a band of 530 
bp (Supplementary fig. 1C). For initial experiments, mice with the FthloxNeo allele were on a 
mixed genetic background (C57BL/6 x 129/Sv) and crossed with nestin-Cre transgenic mice2 
to obtain FthloxNeo/+;Nes-Cre1 mice. Mice were genotyped for Cre by PCR. The Fthlox allele 
was generated by crossing mice carrying the FthloxNeo allele to transgenic mice with β-actin-
FlpE recombinase.3 Mice with the Fthlox allele on mixed genetic background (C57 BL/6 x 
129/Sv) were crossed with the Mx-Cre transgenic mice4 to obtain Fthlox/lox;Mx-Cre (mutant) 
and Fthlox/lox;+ (control) mice. Upon advancement of the analysis, mice were 10 times 
backcrossed with C57BL/6J mice purchased from Harlan (Harlan, Bicester, UK). For initial 
experiments, the ferritin H deletion was induced by 3 intraperitoneal injections of poly-IC 
(Sigma, St. Louis, MO) at 100 mg/kg. In later experiments we switched to a more active 
source of poly-IC (InvivoGen, San Diego, CA). For liver deletion experiments, 1 mg/kg body 
weight was injected 2 times, every third day. For experiments to study deletion in the bone 
marrow, spleen and thymus, it was sufficient to inject mice 5 times with poly-IC (InvivoGen, 
 2
San Diego, CA) at 0.1 mg/kg body weight, every other day. All control mice were littermates 
of mutant mice and were injected with poly-IC. Fthlox/lox;SA-Cre-ERT2 mice generated by 
breeding with SA-Cre-ERT2 mice.5 The hepatocyte-specific ferritin H gene deletion was 
induced with 100 μl tamoxifen (1 mg/ml)(Sigma) on 5 consecutive days. Where indicated 
poly-IC was injected together with tamoxifen on days 1 and 4. 
 Mice were fed with food at a normal iron content of 200 mg/kg. Where indicated mice 
received powdered food supplemented with 25g/kg carbonyl iron for 14 days before and 
during the experiment. 
 
Plasmid constructs. To obtain pKI-MerCreMer, Cre-ERT in pKI-Cre-ERT (gift of Andreas 
Trumpp) was replaced with MerCreMer from pAN-MerCreMer (gift of Michael Reth).  To 
obtain pSH-FTL-d2EGFP, the SV40 promoter-Hygromycin cassette from pBabe-Hygro and a 
cassette containing a CMV promoter and d2EGFP (Clontech, Mountain View, CA) were first 
inserted in opposite orientation into the backbone from the vector ZPCTHG.6 Next the 5’UTR 
of mouse ferritin L cDNA (bases 6-209 of NCBI #AK169159) was amplified by PCR, 
inserted at the N-terminus of d2EGFP. To obtain ferritin H expression vectors for the 
wildtype and mutant (62E→K;65H→G), myc-AUF1 in SLHGC-MYCAUF6 was replaced 
with a PCR amplified Fth cDNA (BC012314). 
 
Mouse embryonic fibroblasts. Cells were derived from FthloxNeo/loxNeo and FthloxNeo/+ mice 
using a standard protocol. Cells were cultured in DMEM-10% FCS. Initially FthloxNeo/loxNeo 
was transformed with pKI-Cre-ERT to obtain Fth∆/∆. However, following selection with 2 
μg/ml puromycin, the deletion occurred spontaneously in absence of tamoxifen treatment in 
96% of the cells. The Fth∆/∆ and Fth+/∆ cells generated this way were used only for LD50 
determinations and for Fth overexpression by transformation with both pBSWITCH and 
SLHGCG-FtH or FtH mutant.6 A Fthlox/lox cell line was generated by subcloning of 
FthloxNeo/loxNeo cells transfected with pOG44 (Invitrogen, Carlsbad, CA), which expresses Flip 
recombinase. Subsequently we generated a cell line that does not delete ferritin H 
spontaneously. For this, FthloxNeo/loxNeo cells were infected with pKI-MerCreMer retrovirus and 
selected on 2 μg /ml puromycin. A clone permissive for deletion with 1 μM 4-OH tamoxifen 
was transformed with the retrovirus pSH-FTL-d2EGFP. Following selection with 200 µg/ml 
hygromycin, the cell population was tested for ferric ammonium citrate- and desferrioxamine-
regulated d2EGFP expression. Cells were sorted with a FACSAria (Becton Dickinson, 
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Franklin Lakes, NJ) for high and intermediate levels of GFP expression. The sorted cells 
(FTL-GFP) were used for all cell culture of iron toxicity tests. 
 
FACS analysis of iron toxicity. To assess cell viability, the cell titer non-radioactive cell 
proliferation assay was used (Promega, Madison, WI). To test mitochondrial depolarization 
and cell membrane integrity, cells were trypsinized and stained in DMEM at 37°C for 10 min 
with 250 nM tetramethyl rhodamine methyl ester (TMRM) (Sigma) and 2 µg/ml 7-amino-
actinomycin D (7aaD) (Sigma). At least 10,000 events were acquired with a FACScan 
(Becton Dickinson) using channels 1, 2, and 3 for GFP, TMRM, and 7aaD respectively. The 
% increase in mean GFP fluorescence was measured in a window of coloured cells 
(Supplementary fig. 3). To measure ROS, cells were washed in Hepes-buffered saline and 
stained 30 min at 37°C with 10 μM 2',7'-dichlorodihydrofluorescein diacetate (H2DCFDA) 
(Molecular Probes, Eugene, OR) followed by propidium iodide (PI) (Sigma). The 
dichlorofluorescein (DCF) product was measured in channel 1 and PI in channel 3 for at least 
3,000 cells. ROS activity was calculated from DCF as the % increase in mean fluorescence 
above untreated control cells. Cell Quest was used for analysis. To measure mitochondrial 
permeability transition (MPT), cells were incubated with 1 μM calcein AM (Biotium, 
Hayward CA) and 1 mM cobalt chloride (Sigma) in conjunction with TMRM and 7aaD prior 
to FACS analysis.7, 8 The fluorescent calcein product of calcein AM hydrolysis was read in 
FACScan channel 1 and analysed with FloJoe. Mitoquinone9 (0.5 μM) (gift of Michael 
Murphy), 20 μM Ebselen10 (Sigma), 5 μM trifluoroperazine (Sigma) or 4 μM cyclosporin A 
were added as inhibitors together with iron salt. 
 
Real-time PCR assays. Deletion of the ferritin H gene in Fthlox/lox;Mx-Cre mutant mice was 
assessed by real-time PCR on genomic DNA prepared by DNAeasy kit (Qiagen, Hilden, 
Germany) and on cDNA prepared from total RNA (RNAeasy kit, Qiagen). Real-time PCR 
assay was performed using LightCycler (Roche Diagnostics, Rotkreuz, Switzerland) either 
with dual labeled probe (FAM/TAMRA) or with SYBR green dye. For a detailed list of 
primers see Supplementary table 2. PCR measurements of genomic DNA were normalized to 
the 18S rRNA gene, ferritin H cDNA to of mouse acidic ribosomal phosphoprotein P0 cDNA 
or TATA box binding protein cDNA, and cDNAs of all other genes to GAPDH, HPRT and β-
actin cDNA.  
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Biochemical assays. Tissue iron was determined by the bathophenanthroline method on acid-
solubilized wet tissue.11 Hematocrit was determined by standard procedures. Hemoglobin was 
measured by the cyanmethemoglobin method (Sigma). Serum iron and total iron binding 
capacity were measured with the Diagnostic Chemicals kit (DCL, Charlottetown, Canada). 
Alanine transaminase (ALT; GPT; EC 2.6.1.2) and aspartate transaminase (AST; GOT; EC 
2.6.1.1) activity was measured in serum using Stanbio reagents (Stanbio, Boerne, TX). 
 
Immunoblotting. Liver (100 mg) was homogenized in 1 ml hypotonic extraction buffer (25 
mM HEPES, pH 7.5, 5 mM MgCl2, 1 mM EGTA) with a protease inhibitor cocktail 
(Complete Mini, Roche) and centrifuged at 15,000xg for 15 min. Protein of the supernatant 
(100 μg/sample) was separated by SDS-polyacrylamide gel electrophoresis and transferred to 
Optitran BA-S 83 cellulose nitrate membranes (Schleicher & Schuell BioScience, Dassel, 
Germany) for ferritin, or Hybond nitrocellulose membranes (Amersham, Buckinghamshire, 
UK) for tubulin. Membranes were blocked with 5% non-fat dry milk (1 h) in TBST buffer 
(100 mM Tris-HCl, pH 7.8, 150 mM NaCl, 0.1% Tween-20), and then incubated with rabbit 
anti-ferritin H chain antibody H-53 (1:1,000, Santa Cruz Biotechnology, Santa Cruz, CA), or 
monoclonal anti-γ-tubulin antibody (T6557, 1:5,000, Sigma) at 4oC, overnight. HRP-
conjugated secondary antibody (2 h, 25oC), enhanced chemiluminescence reagent, and 
SuperRX (Fujifilm, Tokyo, Japan) were used to visualize immuno-reactive proteins. 
 
Macrophage isolation. Splenic macrophages were enriched by centrifugation for 30 min at 
4oC on an iso-osmotic Percoll (Pharmacia, Uppsala, Sweden) step gradient.12 
 
Histology and immunofluorescence microscopy. Iron stores in ferritin were histochemically 
visualized by the Perl’s Prussian blue staining. Hematoxylin-eosin staining was done with a 
standard protocol. The terminal transferase dUTP nick end labelling (TUNEL) assay was 
done on paraffin embedded sections with the in situ Cell Death Detection Kit (Roche). For 
immunofluorescence microscopy, dissected tissues were embedded in OCT (Sakura Finetek, 
Torrance, CA) without prior fixation. Cryostat sections (8 μm) on Superfrost/Plus glass slides 
(Thermo Fisher Scientific, Waltham, MA) were air-dried overnight, and then fixed in ice-cold 
acetone for 10 min. After rehydration, sections were blocked using 0.1% bovine serum 
albumin (BSA) and 1–4% normal mouse serum (NMS). Ferritin H and L were visualized 
using specific rabbit antibodies H53 and H45 (Santa Cruz Biotech, Santa Cruz, CA), 
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respectively, and FITC-labeled anti-rabbit IgG. To stain most macrophage populations rat 
anti-CD11b and rat anti-F4/80 antibodies were combined (diluted in PBS containing 0.1% 
BSA, 1% normal mouse serum) and detected using a goat-anti-rat biotinylated antibody 
followed by streptavidin Cy3 (Jackson ImmunoResearch, West Grove, PA).  
 
Statistical methods. Data of experimental versus control mice were compared for the 
significance of changes by calculating p-values using Student’s T test. 
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Supplementary Table 1. Hematological parameters
Fth lox/lox Fth ∆/∆ Fth lox/lox Fth ∆/∆ Fth lox/lox Fth ∆/∆
Hemoglobin (g/dl) 17.5 ± 2.0 17.2 ± 0.8 21.5 ± 1.3 20.8 ± 0.6 22.1 ± 1.6 21.8 ± 1.6
Hematocrit (%) 40.7 ± 1.6 38.1 ± 0.6 43.4 ± 4.4 41.5 ± 2.8 44.6 ± 1.4 44.7 ± 4.2
n=4 in each group
10 days 30 days 120 days
Supplementary Table 2. Primers used for RT-PCR and PCR measurements.
Gene Primer name Sequence Accession Nr Amplicon
Genotyping
gFth2 forward in exon1 CCATCAACCGCCAGATCAAC  NC_000085 lox     337
gFth1 reverse in intron1 CGCCATACTCCAGGAGGAAC  wt      420
gFth3 in promoter GGCTGTTGTCCTGCTCTAAG   del     520
Cre forward GCCAGGCGTTTTCTGAGCATAC  X03453 884
Cre reverse CACCATTGCCCCTGTTTCACTATC  
LightCycler/Sybr
Hamp1 forward AGAGCTGCAGCCTTTGCAC NM_032541 130
Hamp1 reverse ACACTGGGAATTGTTACAGCATTTA
DMT1 forward GCAGTGGTTAGCGTGGCTTATT NM_008732 74
DMT1 reverse AGACAGACCCAATGCAATCAAA
IREG forward TTGCAGGAGTCATTGCTGCTA NM_016917 101
IREG reverse TGGAGTTCTGCACACCATTGAT
Dcytb forward GCAGCGGGCTCGAGTTTA NM_028593 98
Dcytb reverse TTCCAGGTCCATGGCAGTCT
Heph forward TTGTCTCATGAAGAACATTACAGCAC NM_010417 160
Heph reverse CATATGGCAATCAAAGCAGAAGA
Hfe forward CTGGGACAGCAAGTGCCTACT NM_010424 83
Hfe reverse TCCAGAGCCTGACACCTTAGAGA
TfR1 forward GTTTTTGTGAGGATGCAGACTATCC NM_011638     81
TfR1 reverse GCTGAGGAACTTTCTGAGTCAATG
TfR2 forward GCCATGTTTCTCCGGTTCCT NM_015799 133
TfR2 reverse GGCGCGAGAGCTTATCGA
Tf forward CCATCCCATCACAACAAGGTATC NM_133977 74
Tf reverse GCTAGTGTCCGATGCCTTCAC
Gpx1 forward GCGGCCCTGGCATTG NM_008160 132
Gpx1 reverse GGACCAGCGCCCATCTG
Sod2 forward CACATTAACGCGCAGATCATG NM_013671 100
Sod2 reverse CCAGAGCCTCGTGGTACTTCTC
HO1 forward GCCACCAAGGAGGTACACAT NM_010442 132
HO1 reverse GCTTGTTGCGCTCTATCTCC
Hprt1 forward CCTAAGATGAGCGCAAGTTGAA NM_013556 86
Hprt1 reverse CCACAGGACTAGAACACCTGCTAA
GAPDH forward AATGTGTCCGTCGTGGATCTGA NM_008084 83
GAPDH reverse GATGCCTGCTTCACCACCTTCT
Act β forward GACAGGATGCAGAAGGAGATTACTG NM_007393 124
Act β reverse GCTGATCCACATCTGCTGGAA
Tbp forward CCCCTTGTACCCTTCACCAAT NM_013684 89
Tbp reverse GAAGCTGCGGTACAATTCCAG
LightCycler/TaqMan Primers and Probes
mFeH forward CCATCAACCGCCAGATCAAC NM_010239 85
mFeH reverse GCCACATCATCTCGGTCAAA
mFeH Probe AGTTGTATGCCTCCTACGTCTATCTGTCTATGTCTTGTT
mArbp P0 forward CTTTGGGCATCACCACGAA NM_007475 92
mArbp P0 reverse GCTGGCTCCCACCTTGTCT
mArbp P0 probe ATCAGCTGCACATCACTCAGAATTTCAATGGT
Tf receptor 2
Tf receptor 1
Hfe
TATA box binding 
protein 
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Supplementary figure 1. Targeting the mouse ferritin H gene with loxP and FRT sites. A. Steps 
in the conditional ferritin H deletion are described in detail in Experimental procedures. The targeting 
vector comprised the ferritin H promoter and exon 1 between loxP sites (hatched triangles), 1.5 kb of 
5' and 2.5 kb of 3' flanking sequences. A neomycin selection cassette (Neo) flanked by FRT sites 
(hatched bars) was used for the selection of homologous recombination in ES cells. B. The 
recombination in ES cells was verified by a genomic Southern blot using an intron 1 probe (dashed 
line). C. A recombined ES cell clone carrying the FthloxNeo allele was introduced into blastocysts to 
generate chimeras that transmitted the FthloxNeo through the germ-line. Mice carrying the Fthlox allele 
without the Neo cassette were obtained by breeding with transgenic mice that express the Flip 
recombinase. For routine genotyping of the FthloxNeo, the Fthlox and the Fth− allele, specific primer sets 
were used to amplify as indicated by the black bars. D. Four litters of FthloxNeo;Nes-
Cre1xFthloxNeo;Nes-Cre1 crosses, as the one shown here, were analyzed by tail genotyping. No mice 
with a Fth−/− genotype were born.
D
419 bp
Supplementary figure 2. Analysis of Fthlox/lox and FthΔlΔ mice deleted with hepatocyte-
specific SA-Cre-ERT2 and tamoxifen. For all experiments, 4 control Fthlox/lox and 4 deleted FthΔlΔ
mice were analyzed at day 10, either under normal iron diet (–) or after a high-iron regimen (+).  
A. After deletion of the ferritin H gene, 6-15% liver ferritin H mRNA, normalized to HPRT mRNA, 
remained. B. Liver tissue iron prior and after ferritin H deletion. Under normal diet only about 15% 
of stored liver iron was lost. At high-iron regimen, liver iron accumulated 7-foldand was rapidly, but 
not completely lost from the tissue after ferritin H deletion. C and D. In normally fed mice, serum 
iron levels and transferrin saturation were slightly but not significantly increased after ferritin H 
deletion. E and F. Hepcidin 1 and heme oxygenase mRNA levels normalized to MTBP mRNA 
were not significantly change by the deletion. G and H. Serum iron levels and transferrin
saturation were relatively high in control mice and not significantly changed after ferritin H deletion. 
If anything they were slightly diminished at day 10 after deletion. I and J. Hepcidin 1 and heme
oxygenase 1 mRNA normalized to MTBP mRNA were not significantly changed in iron-loaded 
animals upon ferritin H deletion. K. Serum alanine transaminase (ALT) was only 2-fold increased 
by the ferritin H deletion indicating absence of tissue damage in these mice. L. Upon coinjection of 
poly-IC together with tamoxifen, hepcidin 1 mRNA was slightly, but not significantly induced. 
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Supplementary figure 3. Enlarged version of Fig. 3 E. 
GFth ∆/∆ + Fe+ FeFth lox/lox
Mx-Cre
H
Fth ∆/∆ + FeFth lox/lox + Fe
SA-Cre-ERT2
Supplementary figure 4. Enlarged version of Figs 3 G and H. 
Supplementary figure 5. FACS profiles of d2EGFP expression in mouse embryonic fibroblasts. 
FthloxNeo/loxNeo cells were stably infected with the retroviral vector pSH-FTL-d2EGFP to generate a cell 
population expressing unstable GFP under the translational control of iron regulatory proteins. Cells with 
high to intermediate GFP expression were selected with the FACS. FthΔlΔ cells were derived from this 
population by Cre-mediated gene deletion. These cells were then exposed to increasing amounts of 
ferric ammonium citrate (FAC). The mean fluorescence measured without FAC was 11.7% higher in 
FthΔlΔ cells than FthloxNeo/loxNeo cells. This was significant (p<0.005; n=10). The increase of mean 
fluorescence after addition of FAC was compared to the one before addition and expressed as % 
increase. The data are reported in Figure 5A.
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Supplementary figure 6. Assays of mitochondrial depolarization and cell membrane integrity.
FthloxNeo/loxNeo and FthΔlΔ cells were exposed to various concentrations of ferric ammonium citrate (FAC) for 3, 
6 or 16 h. They were then stained with 250 nM tetramethyl rhodamine methyl ester (TMRM) and 2 µg/ml 7-
amino-actinomycin D (7aaD) in order to measure the extent of mitochondrial depolarization and cell 
membrane integrity, respectively. Typical FACS profiles and the scoring is depicted. The results were 
expressed as % increase of cells in B (depolarized) and C plus D (membrane permeable). The summary of 
results are reported in Figure 5C.
A Non depolarized, membrane intact
B Depolarized, membrane intact
C Non depolarized, membrane not intact
D Depolarized, membrane not intact
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Supplementary figure 7. Measurements of mitochondrial permeability transition. FthloxNeo/loxNeo and 
FthΔlΔ cells were exposed to various concentrations of ferric ammonium citrate for 3, 6 or 16 h. They were 
then stained with tetramethyl rhodamine methyl ester (TMRM), calcein AM/cobalt chloride, and 7-amino-
actinomycin D (7aaD) to measure the extent of mitochondrial depolarization (white bars) and mitochondrial 
permeability transition (black bars) in 7aaD-negative cells, respectively. A. Typical FACS profiles. B. 
Graphical representation of all FACS data expressed as % increase in average fluorescence compared no 
addition of ferric ammonium citrate. C. Effect of cyclosporin A (CSA) on mitochondrial permeability transition 
FthloxNeo/loxNeo cells treated with 80 μg/ml ferric ammonium citrate at 16 h. Note that cyclosporin A reduced the 
permeability transition, but increased the depolarization (n=3 at 3 h and 6 h; n=6 at 16 h).
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